NSE: SAILIFE · 3 November 2026
- Sai Life Sciences Ltd. (SAILIFE) gained 1.03% during the trading session on November 3, 2026, closing at ₹1,558.20 compared to its previous close of ₹1,542.30. The stock moved within a day's range of ₹1,523.30 and ₹1,572.60 after opening higher at ₹1,550.20.
- a press release dated August 06, 2026, titled "Press release for the Un-audited Financial Results for the quarter ended on 30 June 2026".
- Trading volume was 0.83 times the 20-day average daily volume.
Why is Sai Life Sciences share price rising on 3 November 2026?
Sai Life Sciences Ltd. (SAILIFE) gained 1.03% during the trading session on November 3, 2026, closing at ₹1,558.20 compared to its previous close of ₹1,542.30. The stock moved within a day's range of ₹1,523.30 and ₹1,572.60 after opening higher at ₹1,550.20.
The broader market demonstrated positive momentum, with the benchmark Nifty advancing 1.58% while the Nifty Pharma sector index rose 0.42%. Sai Life Sciences outperformed the sectoral benchmark slightly while trailing the headline index. Over shorter horizons, the stock has posted a 5-day return of 4.84% and a 20-day return of 3.10%, building on prior session swings of -0.98% and +3.12%.
Company-specific news flow includes a recent earnings call intimation on October 19, 2026, regarding the upcoming financial results for the second quarter and half year ended September 30, 2026. While operational updates and analyst coverage from firms like Prabhudas Lilladher continue to anchor medium-term sentiment, today's modest uptick appears consistent with broader healthcare sector trends and a continuation of recent positive momentum rather than a single confirmed corporate catalyst.
3.97 lakh shares traded by 3 November 2026 · 03:25 PM IST. This compares with a 20-day average daily volume of 4.81 lakh shares (0.83 times). The five-day average daily volume was 5.57 lakh shares. Separately, the NSE report for 2 November 2026 showed 3.52 lakh shares delivered, representing 55.75% of that day’s traded volume. The same report recorded 53,619 trades.
The 1.03% advance lacks a direct same-day corporate catalyst and appears largely driven by general sector alignment, steady delivery participation, and continuation of recent positive momentum.
Latest Company Developments
a press release dated August 06, 2026, titled "Press release for the Un-audited Financial Results for the quarter ended on 30 June 2026".
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 29.56% on 30 September 2026. This compares with 29.47% on 30 June 2026, a change of +0.09 percentage points.
The filing reported 31 MF/UTI holders.
Research & Brokerage Views
Maintained a positive stance on Sai Life Sciences with a target price of ₹1,620, reflecting confidence in the company's growth trajectory as an integrated CRDMO player.
Named Sai Life Sciences as a top CRDMO pick, outlining multiple structural growth drivers across its discovery, development, and manufacturing operations.
What to Watch Next
- Upcoming financial results and earnings call for the quarter ended September 30, 2026
- Execution progress on global CRDMO client contracts and manufacturing expansions
- Delivery volume trends relative to the 20-day average volume of 0.83x
- Institutional holding adjustments and brokerage target tracking around ₹1,620
Other Dated Coverage
More Sai Life Sciences news and dated analysis →
Frequently Asked Questions
What is the latest Sai Life Sciences company news?
a press release dated August 06, 2026, titled "Press release for the Un-audited Financial Results for the quarter ended on 30 June 2026".
How strong was Sai Life Sciences’s trading volume?
3.97 lakh shares traded, 0.83 times the 20-day average daily volume. The price and volume data are dated 3 November 2026 · 03:25 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.